Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 25/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2025-1-4
Source: Additional file 12: Figure S12
Description: Differentially abundant taxa between the VANM group and Rifampin treatment group.
Abundance in Group 1: increased abundance in R (Rifampin)
Revision editor(s): KateRasheed
